Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy
Lachmann, N, Brennig, S, Hillje, R, Schermeier, H, Phaltane, R, Dahlmann, J, Gruh, I, Heinz, N, Schiedlmeier, B, Baum, C, Moritz, T
Published in Gene therapy (01.11.2015)
Published in Gene therapy (01.11.2015)
Get full text
Journal Article
Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system
Lachmann, N, Brennig, S, Pfaff, N, Schermeier, H, Dahlmann, J, Phaltane, R, Gruh, I, Modlich, U, Schambach, A, Baum, C, Moritz, T
Published in Gene therapy (01.03.2013)
Published in Gene therapy (01.03.2013)
Get full text
Journal Article
Deoxycytidine-kinase knockdown as a novel myeloprotective strategy in the context of fludarabine, cytarabine or cladribine therapy
Lachmann, N, Czarnecki, K, Brennig, S, Phaltane, R, Heise, M, Heinz, N, Kempf, H, Dilloo, D, Kaever, V, Schambach, A, Heuser, M, Moritz, T
Published in Leukemia (01.11.2015)
Published in Leukemia (01.11.2015)
Get full text
Journal Article